Dec 31 (Reuters) - Britain's medicines regulator on Friday approved Pfizer Inc's PFE.N COVID-19 pill, Paxlovid, for people over the age of 18 years with mild to moderate illness who are at high risk of developing severe COVID-19.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil D'Silva)

(( Pushkala.A@thomsonreuters.com ; Twitter: https://twitter.com/pullthekart; Mobile: +91 852 751 3793 ; ))

(c) Copyright Thomson Reuters 2021. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Keywords: HEALTH-CORONAVIRUS/BRITAIN-TREATMENT (URGENT)